Vision Financial Markets’s Corbus Pharmaceuticals CRBP Stock Holding History

Vision Financial Markets’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$127	Hold	14	–	–	﹤0.01%	395
2026 Q1	$132	Hold	14	–	–	﹤0.01%	403
2025 Q4	$114	Hold	14	–	–	﹤0.01%	391
2025 Q3	$178	Hold	14	–	–	﹤0.01%	410
2025 Q2	$97	Hold	14	–	–	﹤0.01%	421
2025 Q1	$75	Hold	14	–	–	﹤0.01%	421
2024 Q4	$165	Buy	+14	New	+$235	﹤0.01%	230

Other funds holding CRBP

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Vision Financial Markets's CRBP Position: Q2 2026 in Review

Vision Financial Markets held its Corbus Pharmaceuticals (CRBP) position steady in Q2 2026 at 14 shares worth $127. The position accounts for ﹤0.01% of the portfolio, ranked #395.

Vision Financial Markets first reported a position in CRBP in Q4 2024 and has held it in 7 quarters since. The position peaked at $178 in Q3 2025. 16 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

Vision Financial Markets held 14 shares of Corbus Pharmaceuticals worth $127 as of Q2 2026.
Vision Financial Markets left its Corbus Pharmaceuticals share count unchanged in Q2 2026.
Corbus Pharmaceuticals made up ﹤0.01% of Vision Financial Markets's portfolio in Q2 2026, its #395 holding.
Vision Financial Markets first reported a position in Corbus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Vision Financial Markets's Corbus Pharmaceuticals position peaked at $178 in Q3 2025.
16 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Vision Financial Markets's 13F filing for Q2 2026, filed 24 Jul 2026.